mucos
gene
transfer
aid
viral
vector
great
interest
field
gene
therapi
dna
vaccin
develop
sinc
earli
day
gene
therapi
deliveri
one
therapeut
gene
cystic
fibrosi
transmembran
conduct
regul
cftr
cdna
airway
epithelia
attempt
correct
defect
associ
cystic
fibrosi
induc
mucos
well
system
immun
site
also
present
attract
target
deliveri
dna
vaccin
mucos
pathogen
especi
infecti
virus
sever
acut
respiratori
syndrom
coronaviru
sar
human
papilloma
viru
hpv
hepat
b
viru
hbv
case
viral
vector
howev
host
immun
system
gener
seri
immun
reaction
vector
creat
potenti
concern
hypersensit
inflamm
overcom
limit
mani
vector
develop
use
vivo
gene
deliveri
respiratori
system
cation
liposom
one
potent
vector
howev
still
low
gene
transfer
effici
respiratori
system
mani
barrier
prevent
success
gene
transfer
via
airway
rout
thick
secret
anion
mucu
glycosaminoglycan
like
prevent
access
carrierdna
complex
epitheli
cell
surfac
may
dilut
alter
composit
complex
barrier
includ
mechan
hindranc
cilia
glycocalyx
presenc
mani
mucos
barrier
liposomedna
complex
lose
physic
integr
destabil
neg
charg
materi
lung
surfact
latter
caus
dna
dissoci
complex
dna
releas
complex
vulner
nucleas
attack
problem
use
liposom
vivo
mucos
gene
transfer
limit
previou
studi
develop
gene
carrier
form
ow
type
cation
lipid
emuls
cation
emuls
success
deliv
report
gene
cell
vitro
presenc
serum
well
known
small
amount
serum
dramat
reduc
transfect
activ
liposomedna
complex
contain
anion
materi
unlik
liposom
carrier
cation
emuls
develop
retain
physic
integr
high
concentr
serum
complex
dna
vitro
dna
releas
test
show
physic
integr
emulsiondna
complex
strong
maintain
even
presenc
anion
polym
acid
heparin
studi
quantifi
effici
cation
emuls
differ
formul
transfer
gene
airway
cell
intranas
instil
transfect
activ
emuls
nasal
caviti
lung
least
time
higher
lipofectamin
lipofectin
dmriec
commerci
avail
liposom
carrier
also
investig
whether
cation
emuls
complex
dna
maintain
integr
presenc
mucos
destabil
neg
charg
heparin
sulfat
natur
lung
extract
bovin
addit
relationship
transfect
activ
stabil
lipid
carrierdna
complex
presenc
mucos
destabil
studi
squalen
heparin
sulfat
tween
purchas
sigma
chemic
co
st
loui
mo
usa
dotap
dope
purchas
avanti
polar
lipid
alabast
al
usa
use
without
purif
dmem
mem
rpmi
fetal
bovin
serum
fb
purchas
gibco
brllife
technolog
new
york
ny
usa
newfectan
kindli
suppli
yuhan
pharmaceut
compani
ltd
korea
water
produc
use
plu
water
purif
system
millipor
corpor
bedford
usa
chemic
reagent
grade
plasmid
consist
cytosol
form
phontinu
pyrali
luciferas
cdna
obtain
plasmid
promega
madison
wi
usa
use
xbai
l
hindiii
subclon
plasmid
invitrogen
plasmid
amplifi
e
coli
strain
purifi
use
qiagen
qiagen
inc
chatsworth
ca
usa
accord
manufactur
instruct
dna
puriti
determin
agaros
gel
electrophoresi
measur
optic
densiti
od
dna
use
studi
emuls
contain
squalen
constitut
oil
phase
concentr
composit
lipid
emulsifi
vari
emuls
prepar
follow
procedur
describ
previous
briefli
lipid
emulsifi
weigh
dispers
water
emulsifierwat
dispers
sonic
clear
icewat
bath
use
probe
type
sonic
high
intens
ultrason
processor
model
sonic
materi
danburi
ct
usa
lipid
solut
ad
oil
turn
sonic
icewat
bath
ca
min
form
emuls
prepar
liposom
carrier
lipid
solut
sonic
ca
min
solut
becam
clear
prepar
lipid
carrier
kept
experi
lipid
composit
prepar
lipid
carrier
optim
transfect
previou
studi
summar
tabl
throughout
paper
compar
transfect
activ
emuls
liposom
made
ident
lipid
composit
refer
liposom
counterpart
liposom
paper
counterpart
liposom
defin
liposom
ident
lipid
composit
emuls
lack
oil
compon
follow
term
use
paper
cd
weight
ratio
cation
lipid
lipid
formul
dna
complex
cdmin
minimum
cd
ratio
form
carrierdna
complex
without
free
dna
agaros
gel
retard
assay
cdopt
cd
ratio
show
highest
vitro
transfect
activ
averag
particl
size
polydispers
lipid
carrier
liposom
emuls
carrierdna
complex
measur
use
photon
correl
spectroscopi
malvern
zetas
malvern
instrument
ltd
uk
describ
previous
emuls
liposom
dilut
time
water
respect
measur
mixtur
contain
plasmid
dna
appropri
amount
carrier
use
measur
size
emulsiondna
complex
dmem
dotapdop
emuls
see
tabl
notat
dotapdop
liposom
complex
prepar
mix
dna
lipid
carrier
dmem
complex
incub
min
room
temperatur
heparin
sulfat
correspond
equival
dna
newfectan
ad
complex
solut
equival
defin
neg
charg
ratio
heparin
dna
ph
incub
room
temperatur
min
sampl
analyz
gel
electrophoresi
agaros
gel
includ
ethidium
bromid
test
protect
dna
complex
nucleas
digest
plasmid
dna
emulsiondna
complex
lipofectaminedna
complex
incub
without
destabil
presenc
uml
dnase
min
dna
sampl
extract
twice
phenolchloroformisoamyl
alcohol
volum
prior
gel
electrophoresi
remov
lipid
oil
human
squamou
cell
carcinoma
rpmi
human
larg
cell
lung
carcinoma
cultur
mem
rpmi
respect
supplement
fb
humidifi
carbon
dioxid
incub
rpmi
cell
never
shown
cell
polar
cultur
condit
cell
seed
cell
per
well
onto
plate
h
transfect
cell
ca
confluent
time
transfect
ng
complex
appropri
amount
carrier
correspond
media
turn
media
ad
test
effect
mucos
destabil
transfect
effici
lipid
formul
equival
heparin
sulfat
newfectan
ad
media
wash
cell
media
test
protect
dna
complex
nucleas
digest
presenc
heparin
lung
surfact
uml
dnase
ad
media
h
incub
cell
wash
media
remov
remain
carrierdna
complex
cell
fed
media
contain
vv
fb
cultur
h
transfect
evalu
express
luciferas
transfect
cell
lyse
ad
lysi
buffer
mm
edta
triton
ph
per
well
one
freezethaw
cycl
supernat
assay
luciferas
activ
use
kit
purchas
promega
luminomet
turner
design
luminomet
model
promega
peak
light
emiss
measur
room
temperatur
luciferas
content
calcul
rel
light
unit
rlu
use
standard
curv
obtain
purifi
firefli
luciferas
sigma
formula
convers
rlu
picogram
rlu
luciferas
valu
express
nanogram
per
well
background
luciferas
activ
organ
measur
lysat
untreat
cell
neglig
rlu
prepar
dnacarri
complex
dna
solut
contain
carrier
solut
dilut
dmem
mix
invers
amount
carrier
use
form
complex
set
cdopt
complex
solut
allow
incub
room
temperatur
min
administr
femal
balbc
mice
week
old
intranas
instil
gener
anesthesia
use
ketamin
hour
later
mice
sacrif
nose
organ
remov
homogen
lysi
buffer
ratio
lysi
buffer
collect
organ
two
freezethaw
cycl
homogen
organ
extract
centrifug
min
rpm
portion
supernat
assay
protein
concentr
use
protein
assay
kit
laboratori
hercul
ca
usa
base
bradford
method
luciferas
activ
express
picogram
per
milligram
tissu
protein
background
luciferas
activ
organ
measur
organ
untreat
mice
neglig
mice
n
anesthet
ether
perfus
chill
salin
pb
paraformaldehyd
pb
perfus
nose
mous
lung
cut
freez
nasal
sampl
isol
nasal
fragment
incub
neutral
buffer
edta
day
decalcif
nasal
bone
isol
lung
nose
mount
oct
freez
compound
mile
tarrytown
ny
usa
frozen
deep
freezer
tissu
cut
serial
cryosect
section
per
group
select
immunostain
detect
express
luciferas
section
wash
twice
pb
contain
tween
pbst
block
skim
milk
pbst
h
room
temperatur
section
wash
incub
h
room
temperatur
goat
polyclon
antibodi
ab
use
dilut
promega
follow
addit
wash
donkey
igg
conjug
peroxidas
promega
appli
h
ab
bind
detect
ad
tetrahydrochlorid
dab
dako
carpenteria
ca
usa
hematoxylin
use
counterstain
stain
detect
sequenti
tissu
section
treat
normal
goat
serum
demonstr
neglig
background
level
experi
cell
higher
background
score
posit
complex
move
along
intranas
tract
barrier
emulsiondna
complex
face
includ
mucos
destabil
neg
charg
polym
nucleas
therefor
stabil
emulsiondna
complex
monitor
observ
competit
exchang
mucos
destabil
dna
emulsiondna
complex
heparin
sulfat
polysaccharid
glycosaminoglycan
famili
newfectan
natur
deriv
pulmonari
surfact
prepar
obtain
bovin
lung
homogen
select
nasal
lung
destabil
respect
studi
perform
dotap
emuls
see
tabl
cdmin
dotap
liposom
use
control
complex
incub
min
room
temperatur
ad
heparin
newfectan
appli
agaros
gel
electrophoresi
figur
dna
complex
complet
releas
addit
heparin
lane
lung
surfact
lane
distinct
contrast
dna
complex
releas
mucos
destabil
lane
present
pale
fluoresc
band
howev
observ
well
occasion
ad
lung
surfact
complex
lane
also
examin
whether
complex
dna
could
protect
enzymat
digest
dnase
presenc
destabil
nake
dna
liposomedna
complex
emulsiondna
complex
incub
first
heparin
newfectan
min
incub
uml
dnase
min
dna
retriev
visual
agaros
gel
figur
nake
dna
complet
digest
dnase
lane
dna
complex
protect
enzymat
digest
condit
lane
releas
dna
complex
ad
heparin
sulfat
lane
newfectan
lane
howev
degrad
complet
enzymat
digest
contrast
dna
emulsiondna
complex
degrad
presenc
destabil
topolog
chang
occur
nick
dna
lane
result
indic
dna
emulsiondna
complex
protect
liposomedna
complex
destruct
effect
mucos
destabil
activ
emulsiondna
complex
diminish
greatli
airway
tract
due
mucos
destabil
sinc
dissoci
dna
complex
subsequ
releas
dna
vulner
nucleas
attack
therefor
transfect
activ
emulsiondna
complex
dnase
digest
evalu
without
destabil
use
human
nasal
squamou
cell
carcinoma
rpmi
human
larg
cell
lung
carcinoma
mimic
vivo
airway
situat
heparin
sulfat
newfectan
ad
destabil
rpmi
respect
experi
transfect
effici
evalu
variou
cd
ratio
find
cdopt
cdopt
valu
cdopt
valu
howev
increas
ad
tween
lipid
formul
dotaptween
emuls
dotapdopetween
emuls
dotaptween
liposom
dotapdopetween
liposom
respect
transfect
activ
differ
formul
cdopt
shown
figur
nake
dna
also
use
control
shown
figur
although
express
level
luciferas
cell
type
vari
transfect
effici
liposom
emuls
increas
ad
lipid
compon
refer
helper
lipid
dope
tween
although
dnase
alon
could
significantli
affect
transfect
activ
liposomedna
complex
cell
line
addit
heparin
sulfat
lung
surfact
dramat
inhibit
transfect
activ
liposomedna
complex
decreas
acceler
undetect
level
ad
dnase
inhibit
might
due
toxic
effect
destabil
judg
number
morpholog
live
cell
data
shown
emuls
system
howev
destabil
attenu
slightli
transfect
effici
complex
origin
effici
maintain
even
mix
media
contain
heparin
lung
surfact
presenc
dnase
cell
system
evalu
effici
vivo
transgen
express
intranas
instil
nake
dna
complex
variou
lipid
carrier
prepar
dnacarri
complex
complex
differ
lipid
carrier
dmem
cdopt
carrier
transfect
effici
differ
carrier
shown
figur
lipofectin
lipofectamin
dmriec
commerci
avail
liposom
carrier
also
use
comparison
liposom
carrier
complex
dna
charg
ratio
cation
lipid
dna
correspond
cd
figur
nake
dna
use
control
luciferas
activ
determin
h
nasal
caviti
lung
commerci
liposomedna
complex
higher
transfect
effici
nake
dna
especi
lipofectamin
dmriec
yield
maximum
express
nasal
caviti
lung
respect
figur
compar
lipofectamin
dmriec
emuls
system
show
robust
luciferas
express
nasal
caviti
lung
figur
highest
transfect
activ
obtain
nasal
caviti
lung
figur
counterpart
liposom
howev
low
luciferas
activ
observ
tissu
lysat
pg
luciferasemg
tissu
protein
tri
explain
reason
differenti
express
level
transfect
intranas
instil
well
known
vivo
deposit
inhal
particl
respiratori
tract
determin
mainli
surfac
charg
particl
size
therefor
studi
investig
whether
particl
size
emulsiondna
complex
affect
differenti
express
transgen
nasal
caviti
lung
end
complex
cd
volum
dna
dose
chang
intranas
administr
fix
cd
valu
surfac
charg
effect
exclud
experiment
condit
averag
particl
size
complex
measur
use
photon
correl
spectroscopi
mean
particl
size
complex
depend
volum
complex
solut
figur
volum
complex
solut
increas
mean
particl
size
decreas
gradual
express
transgen
increas
lung
decreas
nasal
caviti
express
level
dramat
decreas
tissu
due
inact
larg
aggreg
nm
dna
emuls
complex
dna
dose
increas
volum
fix
figur
sinc
administ
volum
fix
concentr
becam
higher
increas
dna
dose
dna
dose
increas
mean
particl
size
increas
express
transgen
lung
decreas
gradual
worthi
note
smallest
dna
dose
produc
maximum
luciferas
activ
lung
lysat
contrast
luciferas
activ
mous
lung
decreas
largest
dna
dose
administ
result
show
clearli
particl
size
emulsiondna
complex
affect
distribut
level
luciferas
express
via
intranas
instil
determin
optim
amount
dna
transgen
express
experi
carri
complex
prepar
mix
dmem
cdopt
describ
figur
administ
topic
nare
balbc
mice
nake
dna
also
inhal
control
luciferas
activ
determin
h
nasal
caviti
lung
figur
nasal
caviti
nake
dna
lipid
formul
complex
follow
express
dna
yield
time
higher
luciferas
activ
nake
dna
lung
mice
administ
dna
express
level
increas
correspond
nake
dna
control
show
higher
express
level
complex
sign
toxic
notic
dna
dose
per
mous
one
main
obstacl
develop
gene
therapi
airway
inabl
current
viral
vector
direct
sustain
express
therapeut
transgen
thu
durat
protein
express
intranas
transfect
use
luciferas
system
also
evalu
transfect
group
highest
level
express
observ
day
nasal
caviti
lung
luciferas
express
persist
day
transfect
dnaemuls
complex
although
degre
declin
steeper
lung
nasal
caviti
express
level
complex
day
remain
tissu
day
figur
contrast
transgen
express
tissu
mice
transfect
nake
dna
complex
liposom
almost
disappear
day
vector
mani
hurdl
overcom
includ
acut
inflamm
mediat
inflammatori
cytokin
induct
cytotox
cell
lead
decreas
persist
transgen
express
product
neutral
antibodi
viral
vector
limit
repeat
viral
vector
administr
contrast
vector
gener
regard
safer
less
immunogen
altern
viral
vector
howev
may
potenti
concern
mucos
gene
transfer
use
cation
emuls
induct
immun
respons
carrierdna
complex
result
lack
persist
transgen
express
check
potenti
advers
respiratori
tract
intranas
day
first
transfect
dna
complex
figur
one
day
similar
gene
express
level
level
obtain
initi
administr
obtain
day
observ
tissu
express
maintain
day
result
show
possibl
repeat
inject
emulsiondna
complex
visual
popul
local
transfect
cell
nasal
caviti
lung
immunohistochem
analysi
carri
intranas
instil
emulsiondna
complex
forti
microgram
complex
administ
nare
describ
figur
figur
luciferas
express
nasal
caviti
lung
detect
immunoperoxidas
stain
situ
immunostain
nasal
serial
section
mice
administ
complex
weak
rare
epithelium
nasal
septum
figur
although
posit
signal
cell
lymphoid
tissu
nalt
figur
high
frequenc
ca
domin
signal
observ
variou
sinus
ca
figur
serial
section
lung
mice
administ
complex
stain
exogen
luciferas
frequent
observ
variou
type
cell
pneumocyt
monocyt
figur
stain
detect
sequenti
tissu
section
treat
normal
goat
serum
demonstr
signal
specif
luciferas
figur
similarli
signal
detect
mice
transfect
complex
contain
empti
plasmid
pcdna
demonstr
specif
luciferas
data
shown
vivo
transfect
activ
evalu
cation
emuls
differ
lipid
formul
intranas
instil
mice
knowledg
one
first
success
demonstr
cation
ow
emuls
effect
airway
gene
carrier
vivo
notabl
dotap
becam
potent
deliv
dna
airway
cell
vitro
vivo
chang
formul
liposom
emuls
enhanc
vivo
transfect
activ
emuls
nasal
caviti
lung
could
explain
number
possibl
one
may
differ
dna
degrad
lipid
carrierdna
complex
mucos
secret
dna
complex
must
surviv
deliv
intact
dna
target
cell
nasal
mucosa
mucos
secret
mani
anion
materi
compet
substitut
dna
complex
releas
dna
vulner
nucleas
attack
substitut
assum
major
destabil
mechan
lipiddna
complex
addit
mucos
secret
recent
report
reveal
lung
surfact
markedli
inhibit
cation
gene
transfer
stabil
dnaemuls
complex
investig
observ
competit
exchang
heparin
newfectan
dna
complex
presenc
dnase
counterpart
liposomedna
complex
plasmid
began
dissoci
equival
heparin
increas
uniti
similar
pattern
observ
commerci
liposom
lipofectamin
data
shown
distinct
contrast
emuls
releas
plasmid
presenc
destabil
thu
complex
dna
emuls
extrem
stabl
resist
competit
exchang
anion
proteoglycan
consequ
dna
complex
emuls
could
protect
dnase
attack
observ
conclud
stabl
emulsiondna
complex
provid
necessari
protect
inactiv
mucos
secret
higher
access
activ
dna
airway
epithelia
liposomedna
complex
report
clearli
stabil
complex
relev
transfect
activ
vivo
condit
sternberg
et
al
investig
morpholog
transfect
activ
vitro
vivo
report
abl
obtain
stabl
complex
substitut
cholesterol
dope
helper
lipid
ad
steric
stabil
complex
format
dna
spermidin
complex
show
high
express
transgen
lung
intraven
administr
also
investig
relationship
structur
stabil
vivo
transfect
activ
complex
emuls
chang
oil
compon
emuls
studi
stabl
emuls
squalen
oil
phase
gave
potent
transfect
activ
intraven
administr
observ
demonstr
vivo
transfect
activ
primarili
associ
stabil
complex
investig
morpholog
emulsiondna
complex
use
transmiss
electron
microscopi
tem
trilaurin
select
oil
phase
particular
experi
sinc
solid
sampl
prepar
process
due
high
melt
temperatur
ca
experi
emuls
dna
appear
fulli
combin
cd
form
structur
report
liposom
lose
structur
integr
format
liposomedna
complex
dna
sandwich
lamellar
lipid
sheet
form
hexagon
phase
unlik
liposom
carrier
howev
cation
emuls
even
retain
structur
integr
format
emulsiondna
complex
therefor
believ
differ
structur
emulsiondna
complex
might
one
possibl
explan
superior
liposomedna
complex
airway
gene
transfer
intranas
immun
associ
dna
deliveri
mucos
surfac
throughout
respiratori
gastrointestin
tract
interestingli
mani
transfect
cell
observ
nalt
immunohistochem
analysi
importantli
addit
nalt
signific
level
express
observ
cervic
lymph
node
mice
administr
emulsiondna
complex
data
shown
indic
cation
emuls
could
vivo
deliveri
system
genet
vaccin
pathogen
infect
may
invad
mucos
surfac
may
possibl
emulsiondna
complex
inflammatori
effect
vivo
observ
inflamm
may
relat
presenc
unmethyl
cpg
dinucleotid
sequenc
bacteri
deriv
dna
sign
sever
toxic
howev
notic
symptom
includ
fever
myalgia
observ
period
h
dose
per
mous
summari
demonstr
convincingli
cation
lipid
emuls
use
effect
mucos
gene
carrier
vivo
transfect
effici
emuls
carrier
ca
time
better
commonli
use
commerci
liposom
carrier
increas
transfect
effici
use
emuls
carrier
may
ascrib
increas
probabl
deliv
intact
dna
airway
sinc
complex
strong
insensit
mucos
destabil
consid
numer
cation
lipid
report
effici
mucos
gene
deliveri
dotap
would
interest
explor
formul
evalu
cation
emuls
mucos
gene
deliveri
